Table 2 Demographics and clinicopathological characteristics of AD cases
In cell assays | Sex | Age | Disease duration | PMI | Neuropathological classification | APOE | |
|---|---|---|---|---|---|---|---|
Units | F/M | Years | Month | Hours | A/B/C | Alleles | |
AD 1 | M | 56 | 112 | 13 | 3/3/3 | E3 | E3 |
AD 2 | F | 71 | 15 | 53 | 1/3/3 | E4 | E4 |
AD 3 | F | 86 | 4 | 5 | 2/3/2 | E3 | E3 |
AD 4 | M | 82 | 60 | 28 | 3/3/2 | E3 | E4 |
AD 5 | F | 67 | 72 | 12 | 3/3/2 | E3 | E3 |
AD 6 | M | 76 | 60 | 20 | 3/3/3 | E3 | E4 |